CASANDRA GRIMMETT: Open Payments
NPI 1710490016 · PARSONS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$169 in 11 payments from 9 companies in 2025. Trend: 2023 $122 · 2024 $157 · 2025 $169
Food & beverage: $169
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Corium, LLC | 2 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: CAPLYTA, LEQVIO, Azstarys, REXULTI, FARXIGA, Auvelity, MOUNJARO, Ozempic.
Industry payments across KS — which companies pay providers there.
